Cerity Partners LLC Vertex Pharmaceuticals Inc Transaction History

Cerity Partners LLC

$37.7 Billion
Q1 2024

A detailed history of Cerity Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cerity Partners LLC holds 194,732 shares of VRTX stock, worth $91.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

194,732

Previous 130,895 48.77%

Holding current value

$91.3 Million

Previous $53.3 Million 52.84%

% of portfolio

0.22%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $26 Million - $28.5 Million	63,837 Added 48.77%	194,732 $81.4 Million
Q4 2023 Jan 26, 2024	BUY	$343.0 - $410.68 $20.2 Million - $24.2 Million	58,974 Added 82.0%	130,895 $53.3 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $7.86 Million - $8.42 Million	23,232 Added 47.72%	71,921 $25 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.82 Million - $3.15 Million	8,958 Added 22.55%	48,689 $17.1 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $10.1 Million - $11.5 Million	35,687 Added 882.47%	39,731 $12.5 Million

Q4 2022 Feb 15, 2023	BUY	$285.76 - $321.48 $362,057 - $407,315	1,267 Added 45.62%	4,044 $1.17 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $61,064 - $68,133	223 Added 8.73%	2,777 $804,000
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $170,111 - $211,806	724 Added 39.56%	2,554 $720,000
Q1 2022 Apr 25, 2022	SELL	$221.42 - $260.97 $111,595 - $131,528	-504 Reduced 21.59%	1,830 $478,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $145,325 - $183,452	821 Added 54.26%	2,334 $515,000
Q3 2021 Oct 25, 2021	BUY	$181.39 - $202.99 $7,799 - $8,728	43 Added 2.93%	1,513 $274,000
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $20,061 - $23,657	107 Added 7.85%	1,470 $296,000
Q1 2021 Aug 11, 2021	SELL	$207.02 - $241.31 $6,210 - $7,239	-30 Reduced 2.15%	1,363 $293,000
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $23,186 - $27,026	112 Added 8.74%	1,393 $299,000
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $39,952 - $53,285	193 Added 17.74%	1,281 $303,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $22,497 - $26,672	-88 Reduced 7.48%	1,088 $296,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $3,156 - $4,141	14 Added 1.2%	1,176 $341,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $19,977 - $24,781	100 Added 9.42%	1,162 $276,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $108,528 - $145,765	-651 Reduced 38.0%	1,062 $233,000
Q3 2019 Oct 30, 2019	BUY	$166.23 - $187.09 $17,454 - $19,644	105 Added 6.53%	1,713 $290,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $53,662 - $62,060	-326 Reduced 16.86%	1,608 $295,000
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $71,713 - $85,278	-438 Reduced 18.47%	1,934 $356,000
Q4 2018 Feb 06, 2019	SELL	$151.91 - $192.21 $20,963 - $26,524	-138 Reduced 5.5%	2,372 $393,000
Q3 2018 Nov 15, 2018	BUY	$167.73 - $192.74 $172,426 - $198,136	1,028 Added 69.37%	2,510 $484,000
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $215,957 - $251,880	1,482 New	1,482 $252,000

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Vertex Pharmaceuticals Inc Transaction History